Liquid biopsies describe a spectrum of methods that can derive various diagnostic information from a simple blood sample. This project focuses on a novel patent-protected methods developed by Prof. Speicher and his team that are applicable to circulating cell-free DNA (cfDNA). The main goal is to establish a world-leading laboratory that focuses on analyzing these blood samples quickly and providing intuitive and well-explained results. These results would be the very first of their kind to be made available to clinicians, researchers and patients. They open up entirely new possibilities in precision medicine and for people who want to proactively monitor their health.